1 / 4

Stem Cell Market

The stem cell market size was USD 14.7 billion in 2020 and is estimated to register a substantial CAGR of over 8.8% during the forecast period, 2021u20132028. The growth of the market is attributed to increasing number of clinical trials and the growing adoption of stem cell therapies globally.

Download Presentation

Stem Cell Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Stem Cell Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast The stem cell marketsize was USD 14.7 billion in 2020and is estimated to register a substantial CAGR of over 8.8% during the forecast period, 2021–2028. The growth of the market is attributed to increasing number of clinical trials and the growing adoption of stem cell therapies globally. Stem cell refers to biological cells that can differentiate into other types of cells. Furthermore, several types of stem cells are used for therapeutic purposes. With numerous applications at the clinical stage for various diseases, these are being explored extensively by a large number of biopharmaceutical companies in recent times. The Covid-19 pandemic had a positive impact on the stem cell market. Ggovernment organizations in several research institutes, countries, and many biotech and pharmaceutical firms are aiming for rapid and effective technologies for the fast diagnosis of COVID-19. According to a research article published in the scientific journal Aging and Disease (2020), mesenchymal stem cells are a safe and effective approach to the treatment of COVID-19; therefore, least 10 projects have been registered in the official international registry for clinical trials, implicating the use of mesenchymal stem cells to patients with corona virus pneumonia. Market Trends, Drivers, Restraints, and Opportunities  Growing demand for biologics, technological advancement in stem cell therapeutics, and a growing focus on the development of personalized medication are expected to drive the market during the forecast period. Increasing focus on the treatment of neurological disorders is likely to boost the stem cell market. 

  2. Growing popularity of personalized medicines is estimated to propel the market. Researchers are discovering new procurement methods that can be further applied for developing personalized medicines. R&D investment and technological advancement in stem cell marketare expected to offer lucrative opportunities for the market players.  Sample - https://growthmarketreports.com/request-sample/1171 Market Segment Insights The adult stem cell segment is projected to constitute a large market share Based on product type, the stem cell market is segregated into adult stem cell, human embryonic cell, pluripotent stem cell, and other product types. The adult stem cell segment is expected to account for a key share of the market during the forecast period owing to the presence of minimal controversial issues concerning immune-rejection, ethics, and tumorigenesis. Furthermore, the application of ASCs in regenerative medicines is likely to boost the market; however, pluripotent stem cell segment is anticipated to expand at a rapid pace during the forecast period owing to increasing investment for developing regenerative medicines using iPSC, ensured reproducibility and maintenance which is capable of differentiation into all the cell types and high proliferative ability. The oncology disorders segment is expected to register a substantial CAGR Based on applications, the stem cell market is divided into neurological disorders, orthopedic treatments, oncology disorders, injuries and wounds, cardiovascular disorders, and other applications. The oncology disorders segment accounts for a key share of the market and is estimated to propel even further over the forecast period owing to increasing burden of cancer. According to the World Cancer Research Fund, in 2018, there were an estimated 18 million cancer cases around the globe which is anticipated to boost the segment growth. The allogeneic stem cell therapy segment is anticipated to dominate the market Based on treatment type, thestem cell market is divided into allogeneic stem cell therapy, auto logic stem cell therapy, and syngeneic stem cell therapy. The allogeneic stem cell therapysegment accounts for a key share of the market and is anticipated to grow at a rapid pace over the forecast period owing to their graft vs-cancer effect for the treatment of cancer, it helps stem cells from the donor which can use their immune system cell for killing cancer cells. Moreover, these are commonly used for treating different types of cancers such as lymphomas, leukemias, and myelomas. North America is expected to dominate the market In terms of geography, the market is broadly classified into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is anticipated to expand at a robust CAGR during the forecast period. Several factors such as advanced healthcare infrastructure, the presence of key players engaged in developing stem cell therapies, supportive reforms from healthcare organizations, extensive R&D, and strong reimbursement policies in this region is expected to drive the market growth in near future. Inquiry- https://growthmarketreports.com/enquiry-before-buying/1171

  3. Competitive Landscape Key players competing in the stem cell market include Thermo Fisher Scientific, Becton, Dickinson and Company, Stemcell Technologies Inc., Merck KGaA(Sigma Aldrich), and PLURISTEM THERAPEUTICS INC. Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance,  In August 2020, Cipla and Stempeutics joined forces to launch Stempucel cell therapy to treat critical limb ischemia. In March 2021, OrganaBio started HematoPAC HSC-CBCD34 hematopoietic stem cell (HSC) product, which aids in supporting HSC-based allogeneic cell therapies.  About Growth Market Reports: GMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. Contact: Growth Market Reports Phone: +1 909 414 1393 Email: sales@growthmarketreports.com Web: https://growthmarketreports.com Follow Us: LinkedIn | Twitter

More Related